Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
Primary objective to evaluate the effect of a 12-week treatment period with prandial
administration of Technosphere Insulin on glucose control in subjects with T2 DM. Secondary
objective is to Evaluate the safety and tolerability of a 12-week treatment period of
Technosphere Insulin and Technosphere Placebo.